Benzinga's Top Initiations - Aemetis (NASDAQ:AMTX)

Credit Suisse initiated coverage of Allergan plc AGN with a Outperform rating. The price target for Allergan is set to $327. Allergan shares rose 1.09 percent to $251.70 in pre-market trading.
Analysts at Piper Jaffray initiated coverage of Syros Pharmaceuticals Inc SYRS with a Overweight rating. Syros Pharmaceuticals shares rose 4.80 percent to $12.00 in pre-market trading.
Pacific Crest initiated coverage on Level 3 Communications, Inc. LVLT with a Sector Weight rating. Level 3 Communications shares rose 0.94 percent to close at $56.90 on Thursday.
Analysts at Morgan Stanley assumed VMware, Inc. VMW with a Overweight rating. The price target for VMware is set to $86. VMware shares gained 0.70 percent to $72.05 in pre-market trading.
Analysts at Oppenheimer initiated coverage on Global Medical REIT Inc GMRE with a Outperform rating. The price target for Global Medical REIT is set to $12. Global Medical REIT shares rose 2 percent to close at $10.73 on Thursday.
Analysts at Bank of America initiated coverage on Casey's General Stores Inc CASY with a Buy rating. Casey's shares gained 0.59 percent to $134.30 in pre-market trading.
Analysts at FBR Capital initiated coverage on Aemetis Inc AMTX with a Market Perform rating. Aemetis shares dropped 0.50 percent to close at $1.99 on Thursday.
Analysts at Cowen & Co. initiated coverage on Syros Pharmaceuticals Inc SYRS with a Outperform rating. Syros Pharmaceuticals shares gained 4.80 percent to $12.00 in pre-market trading.

Market News and Data brought to you by Benzinga APIs